TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

Clinical trial NCT03849651 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03849651
Sponsor: St. Jude Children's Research Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)NK-Cell Leukemia Hodgkin Lymphoma Non Hodgkin Lymphoma (NHL)Juvenile Myelomonocytic Leukemia (JMML)Chronic Myeloid Leukemia (CML)

Start date: 2019-01-31
Primary completion: 2024-08-07
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.